Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of gene expression in early-stage ovarian cancer.
Marchini S, Mariani P, Chiorino G, Marrazzo E, Bonomi R, Fruscio R, Clivio L, Garbi A, Torri V, Cinquini M, Dell'Anna T, Apolone G, Broggini M, D'Incalci M. Marchini S, et al. Among authors: fruscio r. Clin Cancer Res. 2008 Dec 1;14(23):7850-60. doi: 10.1158/1078-0432.CCR-08-0523. Clin Cancer Res. 2008. PMID: 19047114
Unique features of the mode of action of ET-743.
D'Incalci M, Erba E, Damia G, Galliera E, Carrassa L, Marchini S, Mantovani R, Tognon G, Fruscio R, Jimeno J, Faircloth GT. D'Incalci M, et al. Among authors: fruscio r. Oncologist. 2002;7(3):210-6. doi: 10.1634/theoncologist.7-3-210. Oncologist. 2002. PMID: 12065793 Free article. Review.
High-performance liquid chromatographic assay for the determination of the novel C-Seco-taxane derivative (IDN 5390) in mouse plasma.
Zaffaroni M, Frapolli R, Colombo T, Fruscio R, Bombardelli E, Morazzoni P, Riva A, D'Incalci M, Zucchetti M. Zaffaroni M, et al. Among authors: fruscio r. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Nov 15;780(1):93-8. doi: 10.1016/s1570-0232(02)00436-1. J Chromatogr B Analyt Technol Biomed Life Sci. 2002. PMID: 12383484
PRL-3 phosphatase is implicated in ovarian cancer growth.
Polato F, Codegoni A, Fruscio R, Perego P, Mangioni C, Saha S, Bardelli A, Broggini M. Polato F, et al. Among authors: fruscio r. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6835-9. doi: 10.1158/1078-0432.CCR-04-2357. Clin Cancer Res. 2005. PMID: 16203771
DeltaNp63 expression is associated with poor survival in ovarian cancer.
Marchini S, Marabese M, Marrazzo E, Mariani P, Cattaneo D, Fossati R, Compagnoni A, Fruscio R, Lissoni AA, Broggini M. Marchini S, et al. Among authors: fruscio r. Ann Oncol. 2008 Mar;19(3):501-7. doi: 10.1093/annonc/mdm519. Epub 2007 Nov 12. Ann Oncol. 2008. PMID: 17998283 Free article.
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis.
Fruscio R, Colombo N, Lissoni AA, Garbi A, Fossati R, Ieda' N, Torri V, Mangioni C. Fruscio R, et al. Br J Cancer. 2008 Feb 26;98(4):720-7. doi: 10.1038/sj.bjc.6604231. Epub 2008 Feb 5. Br J Cancer. 2008. PMID: 18253120 Free PMC article. Clinical Trial.
Synchronous early-stage endometrial and ovarian cancer.
Signorelli M, Fruscio R, Lissoni AA, Pirovano C, Perego P, Mangioni C. Signorelli M, et al. Among authors: fruscio r. Int J Gynaecol Obstet. 2008 Jul;102(1):34-8. doi: 10.1016/j.ijgo.2007.12.012. Epub 2008 Mar 17. Int J Gynaecol Obstet. 2008. PMID: 18342863
250 results